Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients With Cancer
Author(s) -
Federico Pérez,
Javier A. Adachi,
Robert A. Bonomo
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu612
Subject(s) - stenotrophomonas maltophilia , acinetobacter baumannii , medicine , klebsiella pneumoniae , pseudomonas aeruginosa , antibiotics , microbiology and biotechnology , antibiotic resistance , acinetobacter , gram negative bacteria , stenotrophomonas , klebsiella , escherichia coli , bacteria , pseudomonas , biology , biochemistry , genetics , gene
Patients with cancer are at high risk for infections caused by antibiotic resistant gram-negative bacteria. In this review, we summarize trends among the major pathogens and clinical syndromes associated with antibiotic resistant gram-negative bacterial infection in patients with malignancy, with special attention to carbapenem and expanded-spectrum β-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia--all major threats to our cancer patients. Optimal therapy for these antibiotic-resistant pathogens still remains to be determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom